BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25304288)

  • 1. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.
    Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR
    Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.
    Faisal FA; Sundi D; Cooper JL; Humphreys EB; Partin AW; Han M; Ross AE; Schaeffer EM
    Urology; 2014 Dec; 84(6):1434-41. PubMed ID: 25432835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Sundi D; Ross AE; Humphreys EB; Han M; Partin AW; Carter HB; Schaeffer EM
    J Clin Oncol; 2013 Aug; 31(24):2991-7. PubMed ID: 23775960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy.
    Yamoah K; Walker A; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Dicker AP; Rebbeck TR; Lal P
    Clin Genitourin Cancer; 2015 Apr; 13(2):e65-72. PubMed ID: 25450037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
    Weprin SA; Parker DC; Jones JD; Kaplan JR; Giusto LL; Mydlo JH; Yu SS; Lee DI; Eun DD; Reese AC
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1054-e1059. PubMed ID: 31303559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men.
    Epstein M; Syed K; Danella J; Ginzburg S; Belkoff L; Tomaszewski J; Trabulsi E; Singer EA; Jacobs BL; Raman JD; Guzzo TJ; Uzzo R; Reese AC
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):257-263. PubMed ID: 37821578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of race on biochemical disease recurrence after prostate brachytherapy.
    Yamoah K; Stone N; Stock R
    Cancer; 2011 Dec; 117(24):5589-600. PubMed ID: 21692058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?
    Schreiber D; Chhabra A; Rineer J; Weedon J; Schwartz D
    Clin Genitourin Cancer; 2015 Aug; 13(4):e259-e264. PubMed ID: 25777681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?" Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, Schaeffer EM, Johns Hopkins University, Baltimore, MD. J Clin Oncol 2013; 31(24):2991-7. [Epub 2013 Jun 17]. doi: 10.1200/JCO.2012.47.0302.
    Eggener S
    Urol Oncol; 2014 Aug; 32(6):936. PubMed ID: 25087674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
    Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
    Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy.
    Lee DJ; Ritch C; Desai M; Benson MC; McKiernan JM
    BJU Int; 2011 Jun; 107(11):1741-7. PubMed ID: 20942835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched-pair Comparative Analysis of the Cryo On-Line Data Registry.
    Aminsharifi A; Polascik TJ; Tsivian M; Schulman A; Tsivian E; Tay KJ; Elshafei A; Jones JS
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1073-e1076. PubMed ID: 30054221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
    Faisal FA; Kaur HB; Tosoian JJ; Tomlins SA; Schaeffer EM; Lotan TL
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):552-559. PubMed ID: 30850708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men.
    Murphy AB; Carbunaru S; Nettey OS; Gornbein C; Dixon MA; Macias V; Sharifi R; Kittles RA; Yang X; Kajdacsy-Balla A; Gann P
    Urology; 2020 Aug; 142():166-173. PubMed ID: 32277993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
    Schenk JM; Newcomb LF; Zheng Y; Faino AV; Zhu K; Nyame YA; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW
    J Urol; 2020 Apr; 203(4):727-733. PubMed ID: 31651227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.